Becton Dickinson Total Revenue

Becton Dickinson (BDX) currently reports a total revenue of $21B as of June 2026. That compares with $21B in the prior-year period — down 2.6% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Becton Dickinson's total revenue history and peer comparisons.

Becton Dickinson's total revenue decreased from $21B to $21B — a 2.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Becton Dickinson's total revenue of $21B is lower than the Healthcare sector average of $110B. That is roughly 81.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Becton Dickinson reported $21B in total revenue as of June 2026. That compares with $21B in the prior-year period — down 2.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $21B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Becton Dickinson, and consider following BDX for alerts when major investors trade the stock.